https://www.healthcentral.com/article/first-pangenotypic-hep-c-medication-approved-in-the-us
Hepatitis C

First Pan-Genotypic Hep C Medication Approved in the U.S.

Thinkstock
    Nirah Johnson

    Nirah Johnson

    HepFreeNYC

    Nirah Johnson, LCSW, Director of Program Implementation & Capacity Building NYC Health Department, Viral Hepatitis Program serves as the lead organizer of the NYC Hep B Coalition and Hep C Task Force since 2007.